| [1] Jemal A，Siegel R，Xu J，et al. Cancer statistics，2010[J]. CA Cancer J Clin，2010，60(5)：277-300. [2] Chen W，Zheng R，Zhang S，et al. Report of incidence and mortality in China cancer registries，2009[J]. Chin J Cancer Res，2013，25(1)：10-21. [3] Foster JD，Jones EL，Falk S，et al. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer：a systematic review of the literature[J]. Dis Colon Rectum， 2013， 56(7)：921-930. [4] Hanahan D，Weinberg RA. Hallmarks of cancer：the next generation[J]. Cell，2011，144(5)：646-674. [5] Kanner SB，Reynolds AB，Vines RR，et al. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases[J]. Proc Natl Acad Sci USA，1990，87(9)：3328-3332. [6] Schuuring E，Verhoeven E，Litvinov S，et al. The product of the EMS1 gene，amplified and overexpressed in human carcinomas，is homologous to a v-src substrate and is located in cell-substratum contact sites[J]. Mol Cell Biol，1993，13(5)： 2891-2898. [7] Lee YY，Yu CP，Lin CK，et al. Expression of survivin and cortactin in colorectal adenocarcinoma：association with clinicopathological parameters[J]. Dis markers，2009，26(1)：9-18. [8] Luo ML，Shen XM，Zhang Y，et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance[J]. Cancer Res，2006，66(24)：11690-11699. [9] Timpson P，Wilson AS，Lehrbach GM， et al. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib[J]. Cancer Res，2007，67(19)：9304-9314. [10] Buday L，Downward J. Roles of cortactin in tumor pathogenesis [J]. Biochim Biophys Acta，2007，1775(2)：263-273. [11] Liu HS，Lu HH，Lui MT，et al. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers[J]. Oral Oncol，2009，45(12)：1032-1036. [12] Zhu JW，Ma LL，Huang BY，et al. A pivotal role of cortactin， a CTTN encoding protein，in endocytosis of human colon cancer[J] . Zhonghua Yi Xue Za Zhi，2011，91(6)：385-390. [13] Li Y，Tondravi M，Liu J，et al. Cortactin potentiates bone metastasis of breast cancer cells[J]. Cancer Res，2001， 61(18)：6906-6911. [14] Timpson P，Lynch DK，Schramek D， et al. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor[J]. Cancer Res，2005， 65(8)： 3273-3280. |
